V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 210002961 | 210008697 | 1.74 | 68.2 | Adjuvant (A) | 2017-06-14 | 2017-07-10 | PERTUZUMAB + TRASTUZUMAB | 02 | N | PERTUZUMAB + TRASTUZUMAB | 100315730 |
| 210002964 | 210008699 | 1.61 | 89.6 | Adjuvant (A) | 2017-03-28 | 2017-09-16 | Carboplatin AUC 6 - 10 | 02 | N | CARBOPLATIN | 101507568 |
| 210002965 | 210008700 | 1.52 | 88.4 | Adjuvant (A) | null | 2015-11-01 | null | null | N | CAPECITABINE + PERTUZUMAB + TRASTUZUMAB | 100667877 |
| 210002966 | 210008701 | 1.67 | 67 | Curative (C) | 2017-01-29 | 2017-10-21 | Pertuzumab (Loading) | null | N | PERTUZUMAB | 101746239 |
| 210002971 | 210008702 | null | null | null | null | 2016-09-08 | Pertuzumab (Loading) | 02 | null | PERTUZUMAB | 101127094 |
| 210002976 | 210008703 | 1.59 | 72.7 | Adjuvant (A) | 2015-03-01 | 2019-03-13 | null | null | N | PACLITAXEL + TRASTUZUMAB | 100655685 |
| 210002977 | 210008704 | null | null | null | 2019-06-22 | 2019-09-14 | null | null | null | CARBOPLATIN + PACLITAXEL | 100194669 |
| 210002981 | 210008705 | null | null | null | null | 2018-08-28 | Pertuzumab (Maintenance) | 02 | null | PERTUZUMAB | 100282179 |
| 210002982 | 210008706 | null | null | null | null | 2017-08-15 | TRASTUZUMAB EMTANSINE | null | null | EPIRUBICIN | 101036882 |
| 210002983 | 210008707 | 1.63 | 69 | Neo-adjuvant (N) | 2019-09-17 | 2019-11-29 | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | null | N | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 100403952 |
| 210002984 | 210008708 | 1.7 | 49.75 | Adjuvant (A) | 2019-09-28 | 2019-10-18 | Carboplatin + Docetaxel | 02 | N | CYCLOPHOSPHAMIDE + DOCETAXEL + EPIRUBICIN + FLUOROURACIL | 101104877 |
| 210002986 | 210008710 | null | null | null | null | 2021-06-30 | Carboplatin + Docetaxel | 02 | null | ATEZOLIZUMAB | 101683041 |
| 210002989 | 210008711 | null | null | null | 2019-05-06 | 2019-06-02 | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | null | null | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 100530225 |
| 210002990 | 210008712 | null | 90.7 | null | 2018-04-28 | 2018-07-01 | TCH (21 day Trastuzumab) Maint | null | null | CYCLOPHOSPHAMIDE + EPIRUBICIN + FLUOROURACIL | 101808896 |
| 210002992 | 210008713 | null | 65 | null | 2019-01-26 | 2019-04-05 | Eribulin | 02 | null | ERIBULIN | 101079367 |
| 210002995 | 210008715 | 1.73 | 71.1 | Adjuvant (A) | 2018-08-30 | 2018-09-02 | null | 02 | N | EPIRUBICIN | 101832415 |
| 210002998 | 210008717 | null | 58.05 | null | 2018-10-23 | 2020-07-20 | Capecitabine | null | null | CAPECITABINE | 101435951 |
| 210002999 | 210008718 | 1.74 | 72.7 | Palliative (P) | null | 2018-10-31 | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 02 | N | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 101386322 |
| 210003000 | 210008719 | 1.74 | 71 | Palliative (P) | null | 2016-07-30 | Atezolizumab | 02 | N | CARBOPLATIN + PACLITAXEL | 101053721 |
| 210003001 | 210008720 | 1.56 | 103 | Palliative (P) | 2020-05-29 | 2020-05-31 | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | N | N | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 100250389 |
| 210003002 | 210008721 | null | 87.6 | null | 2018-12-19 | 2019-06-18 | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 02 | null | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 100825509 |
| 210003003 | 210008722 | null | 65 | Neo-adjuvant (N) | null | 2021-02-03 | Capecitabine | null | N | CAPECITABINE | 101285452 |
| 210003004 | 210008723 | 1.62 | 87.1 | Neo-adjuvant (N) | 2021-06-12 | 2021-06-18 | Capecitabine | 02 | N | CAPECITABINE | 100922284 |
| 210003005 | 210008724 | 1.58 | 92.4 | Neo-adjuvant (N) | 2016-10-31 | 2017-01-16 | PERTUZUMAB + TRASTUZUMAB | 02 | N | PERTUZUMAB + TRASTUZUMAB | 100943216 |
| 210003006 | 210008725 | 1.59 | 88.2 | Adjuvant (A) | 2015-11-21 | 2018-11-30 | null | 02 | N | CYCLOPHOSPHAMIDE + EPIRUBICIN + FLUOROURACIL | 100469150 |
| 210003007 | 210008726 | 1.58 | 53.2 | Palliative (P) | 2017-08-04 | 2017-08-18 | Carboplatin + Docetaxel | 02 | N | TRASTUZUMAB EMTANSINE | 101568641 |
| 210003009 | 210008728 | 1.63 | 59 | Palliative (P) | 2016-12-09 | 2017-01-06 | null | Y | N | FULVESTRANT + PALBOCICLIB | 100532925 |
| 210003012 | 210008729 | 1.66 | 59.9 | null | 2017-04-10 | 2018-12-31 | Capecitabine | null | null | CAPECITABINE | 100724223 |
| 210003014 | 210008730 | 1.67 | 71.8 | Neo-adjuvant (N) | 2018-10-07 | 2018-10-07 | Capecitabine | 02 | N | CAPECITABINE | 100010373 |
| 210003018 | 210008733 | 1.58 | 84.4 | Palliative (P) | null | 2019-05-27 | Capecitabine | null | N | CAPECITABINE | 100464647 |
| 210003019 | 210008734 | 1.59 | 97.9 | Palliative (P) | null | 2017-02-02 | Capecitabine | 02 | N | CAPECITABINE | 101165207 |
| 210003025 | 210008735 | 1.56 | 83.6 | Palliative (P) | 2018-12-29 | 2019-03-24 | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 02 | null | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 101486649 |
| 210003027 | 210008737 | null | null | null | null | 2020-09-16 | CARBOPLATIN + GEMCITABINE | null | null | CARBOPLATIN + GEMCITABINE | 101389681 |
| 210003028 | 210008738 | 1.52 | 74.4 | Palliative (P) | 2016-09-21 | 2017-05-10 | Trial Unspecified | 02 | N | CARBOPLATIN + NAB-PACLITAXEL | 101552841 |
| 210003029 | 210008739 | 1.65 | 68.9 | Adjuvant (A) | 2019-04-25 | 2019-09-13 | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 02 | N | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 100927096 |
| 210003030 | 210008740 | 1.56 | null | Palliative (P) | 2018-05-24 | 2018-06-15 | PERTUZUMAB + TRASTUZUMAB | 02 | N | PERTUZUMAB + TRASTUZUMAB | 100711272 |
| 210003031 | 210008741 | 1.71 | 75.5 | null | 2016-12-06 | 2017-03-06 | null | 02 | null | TRIAL UNSPECIFIED | 100220188 |
| 210003034 | 210008742 | 1.75 | 106.5 | null | 2019-10-07 | 2019-10-21 | CARBOPLATIN | 02 | null | CARBOPLATIN | 101051849 |
| 210003041 | 210008746 | null | 49.3 | Adjuvant (A) | 2017-01-25 | 2017-07-16 | Paclitaxel+Trastuzumab 21 day Maint | null | N | CARBOPLATIN + DOCETAXEL | 100486645 |
| 210003042 | 210008747 | 1.56 | 80.3 | null | 2020-07-28 | 2020-07-28 | null | 02 | null | CARBOPLATIN + PACLITAXEL | 100806680 |
| 210003043 | 210008748 | 1.57 | 60 | Palliative (P) | 2017-11-11 | 2018-03-31 | GEMCARBO | null | N | CARBOPLATIN + GEMCITABINE | 100052869 |
| 210003047 | 210008749 | 0 | 70.9 | Palliative (P) | null | 2017-02-08 | PERTUZUMAB + TRASTUZUMAB | N | N | PERTUZUMAB + TRASTUZUMAB | 101063761 |
| 210003048 | 210008750 | 1.56 | 53 | null | 2019-06-03 | 2019-11-19 | Neratinib | 02 | null | NERATINIB | 100215259 |
| 210003050 | 210008751 | 1.58 | 55 | Palliative (P) | 2018-02-28 | 2018-03-06 | null | 02 | N | CARBOPLATIN + DOCETAXEL | 101216599 |
| 210003051 | 210008752 | 1.59 | 95 | Neo-adjuvant (N) | 2020-01-06 | 2020-01-14 | PERTUZUMAB + TRASTUZUMAB | 02 | N | PERTUZUMAB + TRASTUZUMAB | 100926295 |
| 210003054 | 210008754 | 1.65 | 116.2 | null | 2019-03-05 | 2019-03-19 | Capecitabine | null | null | CAPECITABINE | 101102922 |
| 210003055 | 210008755 | 1.58 | 53 | Adjuvant (A) | 2015-12-14 | 2017-02-10 | Capecitabine | 02 | N | CAPECITABINE | 101391093 |
| 210003056 | 210008756 | 1.57 | 55.75 | Adjuvant (A) | 2017-02-13 | 2017-02-28 | Capecitabine | null | null | CAPECITABINE | 100671265 |
| 210003057 | 210008757 | null | null | null | null | 2019-11-03 | Paclitaxel albumin (Abraxane) 21day | 02 | null | CARBOPLATIN + PACLITAXEL | 100576686 |
| 210003059 | 210008758 | 1.6 | 50.7 | Neo-adjuvant (N) | 2020-12-03 | 2021-01-01 | null | 02 | N | FULVESTRANT + PALBOCICLIB | 101512369 |